Exchange: NASDAQ·Updated 07:30 PM EDT
FENC logo

FENC Fennec Pharmaceuticals Inc

$10.64
$0.08
(0.75%)
Today
Closed $10.64
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$375.92M
Vol253,700.00

About FENC

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
50

Neutral Sentiment

How do you feel about FENC?

Advertisement|Remove ads.